MedPath

Tranexamic Acid

These highlights do not include all the information needed to use TRANEXAMIC ACID INJECTION safely and effectively. See full prescribing information for TRANEXAMIC ACID INJECTION. TRANEXAMIC ACID injection, for intravenous use Initial U.S. Approval: 1986

Approved
Approval ID

a4d95a17-9745-4780-b4dc-8683df8ca5bd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 27, 2021

Manufacturers
FDA

Amneal Pharmaceuticals LLC

DUNS: 827748190

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tranexamic Acid

PRODUCT DETAILS

NDC Product Code70121-1398
Application NumberANDA208840
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateFebruary 27, 2021
Generic NameTranexamic Acid

INGREDIENTS (2)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
TRANEXAMIC ACIDActive
Quantity: 100 mg in 1 mL
Code: 6T84R30KC1
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tranexamic Acid - FDA Drug Approval Details